PBSV vs MSFT: Which Stock is Better?
Side-by-side comparison of Pharma-Bio Serv, Inc. and Microsoft Corp in 2026
PBSV
Pharma-Bio Serv, Inc.
$0.50
MSFT
Microsoft Corp
$430.11
Key Metrics Comparison
| Metric | PBSV | MSFT | Winner |
|---|---|---|---|
| Market Cap | $11.45M | N/A | PBSV |
| P/E Ratio | N/A | 26.32 | MSFT |
| EPS (TTM) | $N/A | $15.97 | MSFT |
| Revenue Growth | -0.1% | 0.2% | MSFT |
| Gross Margin | 32.5% | 68.6% | MSFT |
Analyze PBSV
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is PBSV or MSFT a better investment?
Comparing PBSV and MSFT: Pharma-Bio Serv, Inc. has a market cap of $11.45M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between PBSV and MSFT?
PBSV (Pharma-Bio Serv, Inc.) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: PBSV or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: PBSV or MSFT?
MSFT has higher revenue growth at 0.2% vs -0.1% for PBSV.
Which company is more profitable: PBSV or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to 32.5% for PBSV.
Which is the larger company: PBSV or MSFT?
Pharma-Bio Serv, Inc. (PBSV) is larger with a market cap of $11.45M compared to N/A for MSFT.
Should I buy PBSV or MSFT in 2026?
Both PBSV and MSFT have investment merit. PBSV trades at $0.50 while MSFT trades at $430.11. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between PBSV and MSFT stock?
Key differences: Market Cap ($11.45M vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (-0.1% vs 0.2%), Gross Margin (32.5% vs 68.6%).